Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4-week, open-label clinical study

Clinical Study ◽

Attention Deficit ◽

Open Label ◽

An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder

Psychiatry and Clinical Neurosciences ◽

10.1111/j.1440-1819.2010.02159.x ◽

2011 ◽

Vol 65 (1) ◽

pp. 55-63 ◽

Cited By ~ 14

Author(s):

Michihiro Takahashi ◽

Yasushi Takita ◽

Taro Goto ◽

Hironobu Ichikawa ◽

Kazuhiko Saito ◽

...

Keyword(s):

Attention Deficit ◽

Dose Titration ◽

Open Label ◽

Hyperactivity Disorder ◽

Japanese Adults ◽

Label Dose

A clinical study of attention-deficit/hyperactivity disorder in preschool children—prevalence and differential diagnoses

Brain and Development ◽

10.1016/j.braindev.2013.11.004 ◽

2014 ◽

Vol 36 (9) ◽

pp. 778-785 ◽

Cited By ~ 9

Author(s):

Kenji Nomura ◽

Kaori Okada ◽

Yoriko Noujima ◽

Satomi Kojima ◽

Yuko Mori ◽

...

Keyword(s):

Preschool Children ◽

Clinical Study ◽

Attention Deficit ◽

Differential Diagnoses ◽

An Examination of Youth with Attention-Deficit/Hyperactivity Disorder and Language Learning Disabilities: A Clinical Study

Journal of Learning Disabilities ◽

10.1177/002221949602900303 ◽

1996 ◽

Vol 29 (3) ◽

pp. 247-258 ◽

Cited By ~ 19

Author(s):

James Javorsky

Keyword(s):

Learning Disabilities ◽

Clinical Study ◽

Language Learning ◽

Attention Deficit ◽

Hyperactivity Disorder ◽

Language Learning Disabilities

Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2018.0068 ◽

2018 ◽

Vol 28 (10) ◽

pp. 682-689 ◽

Cited By ~ 8

Author(s):

Pei-Yin Pan ◽

An-Ting Fu ◽

Chin-Bin Yeh

Keyword(s):

Attention Deficit ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder ◽

Disruptive Mood Dysregulation Disorder ◽

Mood Dysregulation

Stimulant Treatment Effect on Anxiety Domains in Children with Attention-Deficit/Hyperactivity Disorder With and Without Anxiety Disorders: A 12-Week Open-Label Prospective Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2021.0011 ◽

2021 ◽

Author(s):

Omer Soul ◽

Raz Gross ◽

Dana Basel ◽

Mariela Mosheva ◽

Jonathan Kushnir ◽

...

Keyword(s):

Anxiety Disorders ◽

Prospective Study ◽

Treatment Effect ◽

Attention Deficit ◽

Open Label ◽

Stimulant Treatment ◽

Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: An 18-week, single-center, dose-escalating, prospective, open-label study

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.01.010 ◽

2008 ◽

Vol 30 (1) ◽

pp. 182-189 ◽

Cited By ~ 29

Author(s):

Esther Cubo ◽

Alberto Fern¡ndez Jaén ◽

Celia Moreno ◽

Belén Anaya ◽

Miguel Gonz¡lez ◽

...

Keyword(s):

Attention Deficit ◽

Single Center ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder ◽

Dose Escalating

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

CNS Drugs ◽

10.1007/s40263-017-0487-z ◽

2018 ◽

Vol 32 (1) ◽

pp. 85-95 ◽

Cited By ~ 7

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Caleb Bliss ◽

Brigitte Robertson ◽

Alessandro Zuddas

Keyword(s):

Cognitive Function ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0124 ◽

2018 ◽

Vol 28 (5) ◽

pp. 298-305 ◽

Cited By ~ 6

Author(s):

Drew E. Winters ◽

Sadaaki Fukui ◽

Ellen Leibenluft ◽

Leslie A. Hulvershorn

Keyword(s):

Attention Deficit ◽

Open Label ◽

Hyperactivity Disorder ◽

Disruptive Mood Dysregulation Disorder ◽

Mood Dysregulation

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials

Clinical Therapeutics ◽

10.1016/j.clinthera.2009.08.002 ◽

2009 ◽

Vol 31 (8) ◽

pp. 1844-1855 ◽

Cited By ~ 24

Author(s):

Robert L. Findling ◽

Sharon B. Wigal ◽

Oscar G. Bukstein ◽

Samuel W. Boellner ◽

Howard B. Abikoff ◽

...

Keyword(s):

Clinical Trials ◽

Attention Deficit ◽

Phase Iii ◽

Open Label ◽

Hyperactivity Disorder ◽

Term Tolerability

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

CNS Drugs ◽

10.1007/s40263-018-0514-8 ◽

2018 ◽

Vol 32 (5) ◽

pp. 455-467 ◽

Cited By ~ 6

Author(s):

Tobias Banaschewski ◽

Mats Johnson ◽

Peter Nagy ◽

Isabel Hernández Otero ◽

César A. Soutullo ◽

...

Keyword(s):

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽